rs55907012
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012079.6(DGAT1):āc.455A>Gā(p.Lys152Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,608,698 control chromosomes in the GnomAD database, including 286 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_012079.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGAT1 | NM_012079.6 | c.455A>G | p.Lys152Arg | missense_variant | 5/17 | ENST00000528718.6 | NP_036211.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGAT1 | ENST00000528718.6 | c.455A>G | p.Lys152Arg | missense_variant | 5/17 | 1 | NM_012079.6 | ENSP00000482264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0129 AC: 1965AN: 152190Hom.: 26 Cov.: 33
GnomAD3 exomes AF: 0.0137 AC: 3257AN: 238336Hom.: 36 AF XY: 0.0141 AC XY: 1822AN XY: 129294
GnomAD4 exome AF: 0.0172 AC: 25019AN: 1456390Hom.: 260 Cov.: 37 AF XY: 0.0169 AC XY: 12249AN XY: 723992
GnomAD4 genome AF: 0.0129 AC: 1964AN: 152308Hom.: 26 Cov.: 33 AF XY: 0.0116 AC XY: 861AN XY: 74472
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1.6% of total chromosomes in ExAC, 2.4% European chromosomes - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at